Tiziana Life Sciences Ltd (TLSA) Income Statement
TLSA 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsTLSA revenue and net income
TLSA growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
TLSA quarterly EPS vs estimates
Tiziana Life Sciences beat the analyst EPS estimate in 0 of the last 2 quarters.
TLSA income statement
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of revenue | $234,000 | — | — |
| Gross profit | −$234,000 | — | — |
| Research & development | $10.3M | $5.2M | $10.3M |
| Sales, general & admin | — | — | $0 |
| Total operating expenses | $21.1M | $15.8M | $22.7M |
| Operating income | −$21.1M | −$15.8M | −$22.7M |
| Interest income | $19,000 | $814,000 | $1.2M |
| Interest expense | $18,000 | $6,000 | $12,640 |
| Income before taxes | −$18.4M | −$16.7M | −$21.8M |
| Income taxes | — | −$4.9M | $567,536 |
| Net income | −$18.4M | −$11.9M | −$22.4M |
| EBITDA | −$18.2M | −$16.6M | −$21.7M |
| EPS (diluted) | −$0.15 | −$0.11 | −$0.44 |
| Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $146,000 | $88,000 | $88,000 | $61,000 | $126,000 | $126,000 | $41,000 | $41,000 | −$51,919 | −$41,000 | $46,000 | $56,537 |
| Gross profit | −$146,000 | −$88,000 | −$88,000 | −$61,000 | −$126,000 | −$126,000 | −$41,000 | −$41,000 | −$55,000 | $41,000 | −$46,000 | −$56,537 |
| Research & development | $7.0M | $3.2M | $3.2M | $2.7M | $5.2M | $5.2M | $4.8M | $4.8M | $4.2M | $3.3M | $5.5M | $6.8M |
| Total operating expenses | $12.2M | $8.9M | $8.9M | $9.1M | $12.8M | $12.8M | $6.2M | $6.2M | $14.9M | $11.8M | $10.0M | $12.3M |
| Operating income | −$12.3M | −$9.0M | −$9.0M | −$9.2M | −$12.9M | −$12.9M | −$6.2M | −$6.2M | −$14.9M | −$11.8M | −$10.0M | −$12.3M |
| Interest expense | $18,000 | — | — | $6,000 | — | — | $5,000 | $5,000 | $6,331 | $5,000 | $7,000 | $8,603 |
| Income before taxes | −$12.8M | −$5.6M | −$5.6M | −$8.8M | −$16.0M | −$16.0M | −$8.6M | −$8.6M | −$10.9M | −$8.6M | −$10.9M | −$13.4M |
| Income taxes | — | — | — | −$1.6M | −$6.7M | −$6.7M | $449,000 | $449,000 | — | — | — | — |
| Net income | −$12.8M | −$5.6M | −$5.6M | −$7.2M | −$9.3M | −$9.3M | −$9.1M | −$9.1M | −$10.9M | −$8.6M | −$10.9M | −$13.4M |
| EBITDA | −$12.2M | −$5.5M | −$5.5M | −$8.7M | −$15.9M | −$15.8M | −$8.6M | −$8.6M | −$10.9M | −$8.6M | −$10.8M | −$13.3M |
| EPS (diluted) | — | −$0.05 | — | −$0.07 | −$0.05 | — | — | — | — | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in TLSA's financial statements (latest annual report filed May 1, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
TLSA financial results
Tiziana Life Sciences reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $18.4 million. Diluted earnings per share came to −$0.15.
See the TLSA stock overview for the latest quote and news, or the TLSA chart for price history and technical indicators.
TLSA income statement FAQ
Does Tiziana Life Sciences have revenue?
Tiziana Life Sciences reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is Tiziana Life Sciences profitable?
No. Tiziana Life Sciences reported a net loss of $18.4 million in fiscal 2025.
How much does Tiziana Life Sciences spend on research and development?
Tiziana Life Sciences spent $10.3 million on research and development in fiscal 2025.
What are Tiziana Life Sciences's earnings per share?
Tiziana Life Sciences earned $-0.15 per diluted share in fiscal 2025, compared with $-0.11 a year earlier.
When does Tiziana Life Sciences's fiscal year end?
Tiziana Life Sciences's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on May 1, 2026.